Guangxi Jinxing Pharmaceutical Co.,Ltd is located in Daren Industrial Park, Hechi City, Guangxi, China ,the company was founded in January 2014, with a registered capital of RMB 50 million, covering an area of 115 acres. The company has 376 employees, including 58 people with college degree or above and 10 people with senior titles. The company's main production products are: (I) APIS: metronidazole, Phloroglucinol. (II) Pharmaceutical intermediate: 2-methylimidazole, 2-methyl-5-nitroimidazole, 2,3-dimethyl-1-nitroisourea,Triethyl Silane. (III) Finished-dosage: Metronidazole Tablets, Sanhuang tablets Metamizole Sodium Tablets, Dexamethasone Acetate Tablets, Prednisone Acetate Tablets, Furazolidone Tablets,Glucurolactone Tablets,etc. (IV) Biosynthetic API: DHA, DHB, R-3-aminobutyric acid, vegetable protein, protein peptide, etc. (V) Speciality medical food: small molecule active peptide. We started to produce Metronidazole in 1989, and Metronidazole APIs won the title of ‘Guangxi New Product Hundred Flowers Award and Guangxi High Quality Product’ in 1990, and the company has good development prospect and strong.
Year of Establishment:
2014
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Own Brand
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
Asia,Africa
Other Competitive Advantages:
Patents and Copyrights:
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
